Back to Rankings

GPCR

Structure TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
GPCR vs peer average
34/100
GPCR vs. peer average (D vs. C)
Grade spread
A 1 · B 3 · C 4 · D 1 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MRNA is the first available peer comparator.

Large-cap RNA/modality peer with established commercialization; useful comparator for platform valuation dynamics.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMRNAModerna
GPCR
Structure Therapeutics
MRNA
Moderna
Grade
D
D
Momentum
86
93
Value
41
41
Sentiment
15
22
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs MRNA

GPCR / MRNA
Grade Position
Below peers
GPCR vs. peer average (D vs. C)
34/100
Momentum
86
MRNA
Value
41
GPCR
Sentiment
15
MRNA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GPCR
1
MRNA
MRNA
D
40/100
Even
2
IONQ
IONQ
F
20/100
+1
3
ALNY
ALNY
B
80/100
-2
4
ARQT
Arcutis Biotherapeutics Inc Common
B
80/100
-2
5
OGN
Organon & Co Common
B
80/100
-2
MRNA is the first peer returned for this comparison set.